Is serum lactate dehydrogenase a novel marker for the evaluation of disease severity in the early stage of toxic epidermal necrolysis?
Serum LDH levels can be used as a marker of disease severity in the early stage of TEN.
Apicidin appears to be a novel anti-proliferative agent against pancreatic cancer cells that may reverse chemoresistance by epigenetically regulating MUC4 expression.